Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

L.A. McKeown

August 30, 2019

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

News Daily News

Diabetes Often Goes Unrecognized in Patients Hospitalized With Acute MI

May 07, 2015

News Daily News

缺血检测可预示患有无症状CAD的糖尿病患者的预后

Caitlin E. Cox

October 03, 2014

News Daily News

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Caitlin E. Cox

October 03, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

Presentation

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Presenter: Michael J. Zellweger

September 25, 2014

News Daily News

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Leah Lawrence

August 09, 2011

Advertisement

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Diabetes Progression in Statin-Treated Patients: VA Data

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Young Survivors of Childhood Cancer Have Higher, Earlier Risk of CVD Events

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Diabetes Often Goes Unrecognized in Patients Hospitalized With Acute MI

缺血检测可预示患有无症状CAD的糖尿病患者的预后

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

BARI 2D: Older Age Makes No Difference in Therapies for Diabetics with Stable CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content